Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Freddo

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Neurology|April 1, 1986
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron diseaseL Freddo, R K Yu, N Latov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Monoclonal anti-DNA IgM kappa in neuropathy binds to myelin and to a conformational epitope formed by phosphatidic acid and gangliosidesL Freddo, A P Hays, K G Nickerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2005
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical resultsHope S Rugo, Roy S Herbst, Glenn Liu, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
Antiviral Therapy|February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Neurology|April 1, 1986
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron diseaseL Freddo, R K Yu, N Latov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Monoclonal anti-DNA IgM kappa in neuropathy binds to myelin and to a conformational epitope formed by phosphatidic acid and gangliosidesL Freddo, A P Hays, K G Nickerson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicinR D Christen, E F McClay, S C Plaxe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2005
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical resultsHope S Rugo, Roy S Herbst, Glenn Liu, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2011
Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCVJ F Bergmann, J de Bruijne, D M Hotho, et al.
Antiviral Therapy|February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Pageof 3